Skip to main content
OpenTrials
Completed

NCT Number: NCT04982159

Correlation Between Minimum Inhibitory Concentration and Clinical Outcome of Invasive Fusariosis

Multi-centered, international, observational and retrospective study to analyze the correlation between MIC and clinical outcome in patients with invasive fusariosis.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Universitario Reina Sofía

Córdoba, 14004, Spain

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Invasive fusariosis diagnostic
  • Proof of anti-fungic susceptibility according to EUCAST or CLSI, for the medicine used in the treatment of invasive fusariosis.
  • Available data about anti-fungic medicines used: name of medicine, start and end date of treatment.
  • Available information about clinical outcome of illness after 30 days, 6 weeks and 90 days (dead or alive).
  • Only cases of invasive fusariosis proven or possible will be included.

Exclusion criteria

  • None

Treatment and study plan

There is no intervention. This is an observational study.

Other

There is no intervention. This is an observational study.

Primary outcomes

  1. Clinical Evolution

    Time frame: 6 weeks after diagnosis

    Retrospective evaluation of death rate.

Sponsors and collaborators

Lead sponsor

Maimónides Biomedical Research Institute of Córdoba

Other

Registry information

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jul 29, 2021
Registry last updated
Jun 2, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.